Curtis Ruegg, EVP, Technical Operations at Revance Therapeutics, Inc. (RVNC), sold 2,000 shares at $33.06 ($66K) on 2016-01-06, disclosed to the SEC on 2016-01-08.
Open-market sale of $66k RVNC by EVP, Technical Operations. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| RVNC | SELL | 2016-04-13 | $19K | — | Filing → |
| RVNC | SELL | 2016-03-09 | $20K | — | Filing → |
| RVNC | SELL | 2016-02-10 | $18K | — | Filing → |